enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Zonisamide - Wikipedia

   en.wikipedia.org/wiki/Zonisamide

   Zonisamide is approved in the United States, [2] [12] and United Kingdom [13] for adjunctive treatment of partial seizures in adults and Japan for both adjunctive and monotherapy for partial seizures (simple, complex, secondarily generalized), generalized (tonic, tonic-clonic (grand mal), and atypical absence) and combined seizures. [14]

3. Bupropion/zonisamide - Wikipedia

   en.wikipedia.org/wiki/Bupropion/zonisamide

   Bupropion/zonisamide (former tentative brand name Empatic, Excalia) is an experimental combination of bupropion which was under development for the treatment of obesity. [1] [2] [3] Bupropion is a norepinephrine–dopamine reuptake inhibitor and nicotinic acetylcholine receptor antagonist, while zonisamide is an anticonvulsant acting as a sodium channel blocker, T-type calcium channel blocker ...

4. New weight loss drugs carry high price tags and lots of ... - AOL

   www.aol.com/weight-loss-drugs-carry-high...

   Weight loss cuts mortality risk. When adults with obesity lose weight, their risk of dying is reduced by up to 15%, according to Dinesh Edem, Branch’s doctor and the director of the medical ...

5. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of the human body , weight regulation, by: reducing appetite and consequently energy intake , increasing energy expenditure , redirecting nutrients from adipose to lean ...

6. The Zepbound Shortage Is Over — Here's What to Expect ... - AOL

   www.aol.com/zepbound-shortage-over-heres-expect...

   Eli Lilly’s weight loss drug Zepbound is no longer in short supply, the FDA said, worrying patients who use cheaper, off-brand versions of the drug. On Thursday, Dec. 19, the U.S. Food and Drug ...

7. Lilly's weight-loss drug removed from FDA's shortage list - AOL

   www.aol.com/news/us-fda-says-lillys-weight...

   Diabetes treatment Mounjaro has been on the health regulator's shortage list since late 2022, while weight-loss drug Zepbound was added in April as demand far outstripped supply. The limited ...